Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotech, is advancing PP405, its lead candidate for the ...
Healthcare research with the potential to improve patient outcomes is abundant; however, evidence often fails to be promptly ...
Eli Lilly and the WHO Foundation have partnered to support the World Health Organization’s (WHO) global action plan on the ...
Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern ...
AI in pharmaceuticals spans blue-sky possibilities to immediate practical applications delivering value today. AI-powered ...
London’s King’s Cross tunnel has been illuminated in pink for the first time ever, marking Breast Cancer Awareness Month ...
Bristol Myers Squibb (BMS) has agreed to acquire Orbital Therapeutics in a deal valued at $1.5bn. Robert Plenge, executive VP ...
On a hot July evening, the 2025 Communiqué Awards brought together the best in our industry to celebrate exceptional ...
AstraZeneca has announced an agreement with the US government aimed at lowering the cost of prescription medicines for ...
The second phase of Precision Oncology Ireland (POI), the country’s largest cancer research programme has been launched by ...
AstraZeneca has announced the next phase of its $50bn investment programme to strengthen its US manufacturing network, with ...
Rethink paid + organic AI Overviews can displace ads and organic. Shift some budget to assets that win the excerpt (YouTube, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results